Regeneron’s stock climbs 4% as analyst look past earnings miss to focus on pipeline 0 02.05.2024 20:49 MarketWatch.com Regeneron Pharmaceuticals’ stock reversed early losses to trade higher on Thursday, as analysts looked beyond a first-quarter earnings miss to focus on some of the biotech’s pipeline products. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
